Real-World Outcomes of Radium-223 Therapy in Metastatic Castration-Resistant Prostate Cancer: Predictive Value of PSA Doubling Time and Enzalutamide Continuation. [PDF]
Abe K +14 more
europepmc +1 more source
Atopic dermatitis: pathogenesis, immunology, microbiome, and salivary biomarkers. [PDF]
Abraityte S +3 more
europepmc +1 more source
Safety and potential efficacy of DM199, a tissue kallikrein-1 analogue, for treating pre-eclampsia and fetal growth restriction: study protocol for a South African, hospital-based phase I/II open-label trial. [PDF]
Cluver CA +13 more
europepmc +1 more source
Safety and tolerability of Rinvecalinase Alfa (DM199) for acute ischemic stroke (ReMEDy1). [PDF]
Campbell BC +16 more
europepmc +1 more source
Evolving role of biomarkers beyond prostate‑specific antigen in refining prostate cancer screening: From blood‑based tests to urinary and genetic markers (Review). [PDF]
Li L, Zhang L, Li Z, Chai K, Ren W.
europepmc +1 more source
Role of SOX9 protein in ovarian carcinoma: A molecular insight. [PDF]
Harshitha R +4 more
europepmc +1 more source
Using protease inhibitors to prevent intraperitoneal adhesions: effects of nafamostat mesylate, UAMC-00050, GM6001, and enoxaparin in the cecal ligation and puncture model and the ischemic button model. [PDF]
Plaeke P +10 more
europepmc +1 more source
Inhibitors of Proteases: A Well-Grounded Strategy in Drug Development. [PDF]
Previti S, Ettari R.
europepmc +1 more source
Kallikrein 14 activates the chemoattractant protein chemerin in human skin. [PDF]
Brzoza P +7 more
europepmc +1 more source

